Neoadjuvant Chemotherapy and Transoral Robotic Surgery for Oropharynx Cancer and Quality of Life

Neoadjuvant Chemotherapy and Transoral Robotic Surgery for Oropharynx Cancer and Quality of Life—Reply

Published:2024-06-01 Issue:6 Volume:150 Page:527
ISSN:2168-6181
Container-title:JAMA Otolaryngology–Head & Neck Surgery
language:en
Short-container-title:JAMA Otolaryngol Head Neck Surg

Author:

Sadeghi Nader¹,Mascarella Marco²,Bouganim Nathaniel³

Affiliation:

1. Department of Otolaryngology–Head and Neck Surgery, McGill University Health Centre, Research Institute of McGill University Health Centre, Montreal, Quebec, Canada

2. Department of Otolaryngology–Head and Neck Surgery, McGill University Health Centre, Montreal, Quebec, Canada

3. Department of Oncology, McGill University Health Centre, Montreal, Quebec, Canada

Publisher

American Medical Association (AMA)

Link

https://jamanetwork.com/journals/jamaotolaryngology/articlepdf/2817534/jamaotolaryngology_sadeghi_2024_lr_240002_1717443200.9152.pdf

Reference6 articles.

1. Quality of life after neoadjuvant chemotherapy and transoral robotic surgery for oropharynx cancer.;Silver;JAMA Otolaryngol Head Neck Surg,2024

2. Phase II randomized trial of transoral surgery and low-dose intensity modulated radiation therapy in resectable p16+ locally advanced oropharynx cancer: an ECOG-ACRIN Cancer Research Group Trial (E3311).;Ferris;J Clin Oncol,2022

3. Pathologic response to neoadjuvant chemotherapy in HPV-associated oropharynx cancer.;Sadeghi;Head Neck,2020

4. Neoadjuvant chemotherapy followed by surgery for HPV-associated locoregionally advanced oropharynx cancer.;Sadeghi;Head Neck,2020

5. Neoadjuvant chemotherapy enhances tumor-specific T cell immunity in patients with HPV-associated oropharyngeal cancer.;Samaniego;Head Neck,2023